Yıl: 2020 Cilt: 42 Sayı: 1 Sayfa Aralığı: 50 - 53 Metin Dili: İngilizce DOI: 10.14744/etd.2019.75010 İndeks Tarihi: 26-11-2020

Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma

Öz:
Objective: Whole-body I-131 scanning (WBS) is a standard method in the evaluation of patients with differentiated thyroidcarcinoma (DTC). However, it has some limitations in terms of distinguishing between physiological and pathological traceruptake and in defining the exact anatomical location of pathological foci. The purpose of our study was to determine theadditional diagnostic value of SPECT/CT imaging in patients with DTC.Materials and Methods: A total of 142 patients, each with a history of previous total thyroidectomy and who had undergone diagnostic or post-therapeutic WB imaging, were included in this retrospective study. The distinction between physiological and pathological uptake could not be clearly established and/or the localization of pathological uptake could not beclearly defined on the WBS, both of which were considered inconclusive findings. Subsequently, the regional SPECT/CTimages of these patients were evaluated.Results: The number of pathological foci detected by WBS and SPECT/CT was 64 and 59, respectively. The exact anatomical localization was determined in 85.9% of the lesions with SPECT/CT. Benign accumulations (inflammatory/physiological)were determined in 12.5% of inconclusive foci. In 14.1% of WBS-detected foci, no significant tracer uptake was observed onthe SPECT/CT images. Four additional foci were detected on SPECT/CT (3 thyroid remnants, 1 bone remnant).Conclusion: SPECT/CT improves the specificity of I-131 scanning and contributes to the management of DTC patients.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Vaisman F, Tuttle RM. Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer. Endocrinol Metab Clin North Am 2019; 48(1): 99–108.
  • 2. Medas F, Canu GL, Boi F, Lai ML, Erdas E, Cal ò PG. Predictive Factors of Recurrence in Patients with Differentiated Thyroid Carcinoma: A Retrospective Analysis on 579 Patients. Cancers (Basel) 2019; 11(9): pii: E1230.
  • 3. McDow AD, Pitt SC. Extent of Surgery for Low-Risk Differentiated Thyroid Cancer. Surg Clin North Am 2019; 99(4): 599–610.
  • 4. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19(11): 1167–214.
  • 5. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, et al; European Association of Nuclear Medicine (EANM). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2008;35(10):1941–59.
  • 6. Xue YL, Qiu ZL, Song HJ, Luo QY. Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature. Eur J Nucl Med Mol Imaging 2013; 40(5): 768–78.
  • 7. Ahmed N, Niyaz K, Borakati A, Marafi F, Birk R, Usmani S. Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma. Asian Pac J Cancer Prev 2018; 19(2): 303–8.
  • 8. Van Nostrand D. Radioiodine Imaging for Differentiated Thyroid Cancer: Not All Radioiodine Images Are Performed Equally. Thyroid 2019; 29(7): 901–9.
  • 9. Wong KK, Zarzhevsky N, Cahill JM, Frey KA, Avram AM. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma. AJR Am J Roentgenol 2008; 191(6): 1785–94.
  • 10. Aide N, Heutte N, Rame JP, Rousseau E, Loiseau C, Henry-Amar M, et al. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer. J Clin Endocrinol Metab 2009; 94(6): 2075–84.
  • 11. Schmidt D, Szikszai A, Linke R, Bautz W, Kuwert T. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med 2009; 50(1): 18–23.
  • 12. Menges M, Uder M, Kuwert T, Schmidt D. 131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma. Clin Nucl Med 2012; 37(6): 555–60.
  • 13. Spanu A, Nuvoli S, Gelo I, Mele L, Piras B, Madeddu G. Role of Diagnostic 131I SPECT/CT in Long-Term Follow-up of Patients with Papillary Thyroid Microcarcinoma. J Nucl Med 2018; 59(10): 1510–5.
  • 14. Barwick T, Murray I, Megadmi H, Drake WM, Plowman PN, Akker SA, et al. Single photon emission computed tomography (SPECT)/ computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT. Eur J Endocrinol 2010; 162(6): 1131–9.
  • 15. Chen L, Luo Q, Shen Y, Yu Y, Yuan Z, Lu H, et al. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma. J Nucl Med 2008; 49(12): 1952–7.
  • 16. Spanu A, Solinas ME, Chessa F, Sanna D, Nuvoli S, Madeddu G. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med 2009; 50(2): 184–90.
  • 17. Zilioli V, Peli A, Panarotto MB, Magri G, Alkraisheh A, Wiefels C, et al. Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy. Endocrine 2017; 56(3): 551–9.
  • 18. Wong KK, Sisson JC, Koral KF, Frey KA, Avram AM. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT. AJR Am J Roentgenol 2010; 195(3): 730–6.
APA SEMİRGİN S (2020). Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. , 50 - 53. 10.14744/etd.2019.75010
Chicago SEMİRGİN Sibel Uçak Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. (2020): 50 - 53. 10.14744/etd.2019.75010
MLA SEMİRGİN Sibel Uçak Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. , 2020, ss.50 - 53. 10.14744/etd.2019.75010
AMA SEMİRGİN S Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. . 2020; 50 - 53. 10.14744/etd.2019.75010
Vancouver SEMİRGİN S Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. . 2020; 50 - 53. 10.14744/etd.2019.75010
IEEE SEMİRGİN S "Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma." , ss.50 - 53, 2020. 10.14744/etd.2019.75010
ISNAD SEMİRGİN, Sibel Uçak. "Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma". (2020), 50-53. https://doi.org/10.14744/etd.2019.75010
APA SEMİRGİN S (2020). Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. Erciyes Medical Journal, 42(1), 50 - 53. 10.14744/etd.2019.75010
Chicago SEMİRGİN Sibel Uçak Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. Erciyes Medical Journal 42, no.1 (2020): 50 - 53. 10.14744/etd.2019.75010
MLA SEMİRGİN Sibel Uçak Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. Erciyes Medical Journal, vol.42, no.1, 2020, ss.50 - 53. 10.14744/etd.2019.75010
AMA SEMİRGİN S Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. Erciyes Medical Journal. 2020; 42(1): 50 - 53. 10.14744/etd.2019.75010
Vancouver SEMİRGİN S Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma. Erciyes Medical Journal. 2020; 42(1): 50 - 53. 10.14744/etd.2019.75010
IEEE SEMİRGİN S "Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma." Erciyes Medical Journal, 42, ss.50 - 53, 2020. 10.14744/etd.2019.75010
ISNAD SEMİRGİN, Sibel Uçak. "Usefulness of SPECT/CT Imaging in the Management of Patients with Differentiated Thyroid Carcinoma". Erciyes Medical Journal 42/1 (2020), 50-53. https://doi.org/10.14744/etd.2019.75010